Cargando…
Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2
Human induced pluripotent stem cells (hiPSCs)-patient specific are an innovative tool to reproduce a model of disease in vitro and summarize the pathological phenotype and the disease etiopathology. Myotonic dystrophy type 2 (DM2) is caused by an unstable (CCTG)n expansion in intron 1 of the CNBP ge...
Autores principales: | Spitalieri, Paola, Talarico, Rosa V., Murdocca, Michela, Fontana, Luana, Marcaurelio, Marzia, Campione, Elena, Massa, Roberto, Meola, Giovanni, Serafino, Annalucia, Novelli, Giuseppe, Sangiuolo, Federica, Botta, Annalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074094/ https://www.ncbi.nlm.nih.gov/pubmed/30100878 http://dx.doi.org/10.3389/fphys.2018.00967 |
Ejemplares similares
-
Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine
por: Novelli, Giuseppe, et al.
Publicado: (2023) -
Effects of Simulated Microgravity on Wild Type and Marfan hiPSCs-Derived Embryoid Bodies
por: Spitalieri, Paola, et al.
Publicado: (2021) -
Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids
por: Spitalieri, Paola, et al.
Publicado: (2022) -
Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling
por: Giovannini, Daniela, et al.
Publicado: (2021) -
Dopaminergic differentiation of schizophrenia hiPSCs
por: Hartley, Brigham J., et al.
Publicado: (2015)